Thanks to all afib.no members for two inspiring days at Lysebu September 27-28, 2018!
In planning of the meeting, we aimed to focus on topics that our members have shown interest in. We are grateful to all presenters for their invaluable contributions – and to all attendees for creating a friendly forum full of lively scientific discussions.
Epidemiology – Dr. Emelia Benjamin gave a tour of AF research performed at the Framingham Heart Study, including seminal papers on risk factors and prognostic factors for AF.
Screening – Dr. Mårten Rosenqvist gave an overview of screening for AF – with emphasis on the Swedish STROKESTOP studies.
Imaging – Dr. Håvard Dalen gave a splendid lecture on echocardiography and the left atrium, about challenges and possibilities – the past and the future.
Electrocardiography –Dr. Pyotr Platonov shared his impressive insight into electrocardiographic markers in relation to AF; how atrial fibrillatory rate and heart rate variability may be predictors of outcomes in AF.
Genetics – Dr. Patrick Ellinor lectured on genetic causes of AF and how it may be used in clinical practice, whereas Morten Olesen gave an in-depth talk on genetic variation in the gene encoding the important sarcomeric protein Titin, in relation to AF.
Animal models – Pia Lundegaard showed us how zebrafish may be used to evaluate the function of genetic variants associated with AF. Eva Hesselkilde provided insight into the horse as a model for exercise-induced AF and for evaluation of new therapeutic tools against AF.
Last, we had a great abstract session, in which 5 strong candidates presented results from their AF research. We congratulate Dr. Inger Ariansen, who received the abstract presentation award of NOK 5000,-.
We were happy to see that many of you took the opportunity to meet for cross-institutional collaborations before and after the scientific program.
Remember to save de dates for next year’s meeting, which will be held at Lysebu on September 26-27, 2019!
Chief Biological Sciences Editor at Nature, Francesca Cesari, will attend next year’s meeting. She will enlighten us on how to publish in high-impact journals and give our early-career researchers her best advice on how to present their science in a special session. Don’t miss it!
Afib.no workshop – Exercise and AF, April 12, 2018, at Professorboligen, University of Oslo
The workshop on Exercise and AF brought together 37 AF researchers at Professorboligen, University of Oslo, April 12, in beautiful spring weather.
Keynote speaker, André la Gerche, came all the way from Melbourne, Australia, and gave an excellent talk on the topic: Physical activity, exercise and atrial fibrillation – Current evidence and future opportunities. Bjarne Martens Nes told us the exciting story about the development of “PAI – Physical Activity Index” developed by Ulrik Wisløff’s group, CERG, at NTNU in Trondheim. In addition, Marit Aarønæs, Bente Morseth, Trygve Berge and Erik Ekker Solberg gave talks on AF and exercise-related topics.
We are thrilled to see that our network members have such great interest in the relationship between AF and exercise. As you know, there is ongoing research activity within this field in our network, and members with an particular interest also had the time to meet during the workshop to plan collaborations within afib.no. We look forward to hearing more about the collaboration in the future!
Afib.no 2017 – First Annual Meeting, October 19-20, 2017 at Lysebu, Oslo
We are excited to announce that the first annual meeting of afib.no was a success – bringing together 48 atrial fibrillation researchers from Norway, Denmark and the Netherlands on October 19-20, 2017 at Lysebu, Oslo.
Professor of cardiac arrhythmias and clinical electrophysiologist, Jesper Hastrup Svendsen, from Rigshospitalet, Copenhagen University Hospital and the University of Copenhagen, Denmark, presented the large ongoing LOOP study, a randomized study investigating the health benefits and cost-effectiveness of implantable loop recorders as a screening tool for atrial fibrillation to prevent stroke in patients with risk factors for stroke.
Associate Professor and Clinical Director Michiel Rienstra, Department of Cardiology, University Medical Center Groningen (UMCG), the Netherlands, presented preliminary results from the RACE 3 trial, a randomized trial investigating routine versus aggressive upstream rhythm control for prevention of early atrial fibrillation in heart failure.
Furthermore, a total of 23 researchers from different groups in Norway presented their research projects and results, covering many AF research areas such as epidemiology, health registries & population-based studies, genetics, biomarkers, echocardiography, and clinical studies.
Save the dates for afib.no 2018, which will be held on September 27-28, 2018! See you in Oslo!